自2017年成立以来，精锋医疗累计完成6轮融资，总金额超20亿元，投资方涵盖红杉中国、淡马锡、博 裕资本等头部机构，以及社保基金、中国国企混改基金等"国家队"资金。 精锋医疗上市，为祥峰投资在机器人赛道再添重要IPO案例，这也是该机构在半年内斩获的第二个IPO 项目。近日，中国证券报记者专访了祥峰投资中国基金合伙人刘天然，探讨其硬科技投资的逻辑。 关注临床价值 1月8日，精锋医疗在港股上市，上市首日涨幅超过30%。截至IPO前，精锋医疗股东包含红杉中国、淡 马锡、博裕资本、社保基金、祥峰投资等数十家机构，体现出较高的资本认可度。 回顾其融资历程，2018年，精锋医疗A轮融资吸引了中恒汇金、广远众合、嘉兴繸子等多家机构；2020 年，联想之星、国策资本等现身其Pre-B轮融资；2021年，精锋医疗B轮融资超过5亿元，投资机构包括 红杉中国、淡马锡、博裕资本、祥峰投资、国策投资、三正健康等；2021年的交叉轮融资中，社保基 金、中国国企混改基金、OrbiMed、LYFE Capital、祥峰投资等现身，公司融资额超2亿美元，估值超15 亿美元。 □本报记者 张舒琳 1月8日，手术机器人公司深圳市精锋医疗科技股份有 ...

"手术机器人的终局是智能化" 精锋医疗上市，为祥峰投资在机器人赛道再添重要IPO案例。谈及祥峰投资在精锋医疗发展过程中的角 色，刘天然定位为"共创者"。"在关键节点，我们协助企业聚焦战略、引入淡马锡等全球顶级资本。"她 认为，资本最大的价值，是助力技术成果更好地落地转化。 回顾其融资历程，2018年，精锋医疗A轮融资吸引了中恒汇金、广远众合、嘉兴繸子等多家机构；2020 年，联想之星、国策资本等现身其Pre-B轮融资；2021年，精锋医疗B轮融资超过5亿元，投资机构包括 红杉中国、淡马锡、博裕资本、祥峰投资、国策投资、三正健康等；2021年的交叉轮融资中，社保基 金、中国国企混改基金、OrbiMed、LYFE Capital、祥峰投资等均现身，融资额超2亿美元，估值超15亿 美元。 精锋医疗是祥峰投资合伙人刘天然在香港的第三个IPO项目。2020年，国内手术机器人行业初露锋芒， 精锋医疗刚步入临床阶段。彼时行业热度渐起，但刘天然和团队并未急于出手，而是深入手术室、与医 生访谈、分析患者数据，持续追踪验证团队执行力、产品落地能力、与医生的配合度等指标，串联技 术、临床、政策等全要素判断项目潜力。 最终，刘天然被 ...

思宇MedTech 2025年12月27日， 深圳惟德精准医疗科技有限公司 （简称"惟德精准"）迎来注册六周年庆，同日正式宣布完成超 1.2亿元 人民币B轮融资。 本轮融资 于2025年4月基本完成交割，由 广州金控基金 和 广州天河基金 联合领投， 广州合鼎共投资、上海天使会、工大创投、温州瓯江口投资 及老股东 本草 资本 跟投。 在近几年行业融资环境趋紧的背景下，再次完成大额融资，充分彰显资本市场对惟德精准技术路线、临床价值及商业化能力的高度认可，也为公司加速产品迭代、 拓展海内外市场、实现抗周期稳健发展注入了充足的资金动能。 惟德精准由国家重大人才工程专家领军，多名曾任职德国西门子、中国飞利浦、德国马普所、德国海德堡大学、瑞士伯尔尼大学等相关领域全球知名企业和高校的 海归博士联合创立，是目前国内唯一同时掌握基于术中CT与基于术中超声双技术路径的手术机器人企业。 公司产品可实现智能软组织介入手术，应用场景丰富多元，除CT和超声外，还可兼容CBCT、OBCT等跨平台影像数据， 覆盖穿刺活检、引流，冷冻、微波、射 频、激光、纳米刀消融，粒子植入，腔镜切除定位，经皮肾镜取石，精准给药，胆脾胰穿刺等多种术式 ，使 ...

Core Insights - The surgical robotics industry is experiencing a surge in collaborations with NVIDIA, with over 8 surgical robotics companies announcing partnerships to integrate NVIDIA's advanced AI and robotics platforms into their systems [1][2] - NVIDIA's IGX Thor platform, featuring 5581 FP4 TFLOPS AI computing power and 400GbE network capabilities, represents a significant leap in computational efficiency and perception capabilities compared to previous platforms [1][9] - Companies like EndoQuest Robotics and CMR Surgical are among the first to adopt the IGX Thor platform, aiming to enhance their robotic systems' performance and capabilities [1][10] Collaboration with NVIDIA - EndoQuest Robotics plans to integrate NVIDIA's IGX Thor platform into its next-generation surgical robot [2] - CMR Surgical has become one of the first global adopters of the IGX Thor platform [2] - Other companies such as Johnson & Johnson, XCath, Asensus, Moon Surgical, Virtual Incision, Neptune Surgical, and Stereotaxis have also formed partnerships with NVIDIA to leverage its technology [1][2] Innovations in Automation and Intelligence - Domestic companies like MicroPort, Precision Medical, and Tianzhihang have already introduced surgical robots equipped with advanced imaging, intelligent navigation, surgical planning, and decision support features [3] - Companies like GeroTech have showcased fully automated surgical solutions, achieving higher levels of automation in surgical procedures [3][4] - The collaboration with NVIDIA is expected to further enhance the capabilities of these robots, particularly in real-time perception and decision-making [12] Computational Power as a Foundation - The demand for computational power in surgical robotics is increasing due to the growing complexity of algorithms and clinical requirements [5] - NVIDIA's solutions are seen as essential for meeting the computational needs for real-time environment perception, data processing, and multi-modal data integration [5][6] - The need for high computational power is critical for pre-operative, intra-operative, and post-operative functionalities [6][7] Competitive Landscape - The partnerships with NVIDIA may enable these surgical robotics companies to compete more effectively with established players like Intuitive Surgical's da Vinci system [9][12] - The IGX Thor platform's capabilities, such as enhanced AI vascular recognition and low-latency control, provide a competitive edge for companies like CMR Surgical [10] - The integration of NVIDIA's platforms is expected to accelerate the development of innovative surgical robots, potentially reshaping the competitive landscape [12][14] Future Directions and Challenges - The surgical robotics industry is moving towards greater automation and intelligence, but challenges such as data availability, regulatory hurdles, and ethical considerations remain [15] - The collaboration with NVIDIA is anticipated to play a crucial role in overcoming these challenges and driving innovation in the field [12][15] - The shift towards software-driven and computationally powered surgical robots is expected to continue, with a focus on enhancing automation and intelligence [14][15]

Core Viewpoint - The article discusses the upcoming Global Medical Robotics Conference 2025, highlighting its significance in the field of surgical robotics and the confirmed speakers and topics for the event [2][3][8]. Event Details - The conference is scheduled for September 5-6, 2025, in Beijing, China [3][10]. - Attendees are encouraged to reserve two days for the event due to the depth of discussions and presentations planned [2][3]. Confirmed Speakers and Topics - Notable speakers include Liu Yu from Shanghai MicroPort Medical Robotics, Wang Yu from Beijing Rosenbot Technology, and others focusing on various aspects of surgical robotics [4][5]. - Topics cover advancements in intelligent surgery, the intersection of engineering and medicine in robotic innovation, and experiences with pediatric thoracic surgery robots [4][5]. Industry Participation - Several companies are confirmed to participate, including MicroPort Robotics, Rosenbot, and Xin Jun Te, among others, showcasing their innovations in laparoscopic, orthopedic, and vascular intervention robots [7][28]. - The event will also feature discussions on the supply chain for surgical robots, with companies like TUG Medical and Ai Rui Mai Di involved [7]. Previous Conferences - The article reflects on the success of previous conferences, noting the wealth of information shared and the upcoming white papers on various surgical robot technologies [7].